Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed about the press release pertaining to receipt of Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for the Company’s manufacturing facility at Goa.
The above information is a part of company’s filings submitted to BSE.